Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5793-5799

  Lutz, Charles T ^a,b   Kurago, Zoya B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ALLELES; CARCINOMA, SQUAMOUS CELL; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOMA; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033571487     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Brittenden, J., Heys, S. D., Ross, J., and Eremin, O. Natural killer cells and cancer. Cancer (Phila.), 77: 1226-1243, 1996.
2. Green, L. K., and Griffin, J. Increased natural killer cells in fluids. A new, sensitive means of detecting carcinoma. Acta Cytol., 40: 1240-1245, 1996.
3. Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., and Moreno, M. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer (Phila.), 79: 2320-2328, 1997.
4. Schantz, S. P., and Ordonez, N. G. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat. Immun. Cell Growth Regul., 10: 278-288, 1991.
5. Ljunggren, H. G., and Kärre, K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today, 11: 237-244, 1990.
6. Lanier, L. NK cell receptors. Annu. Rev. Immunol., 16: 359-393, 1998.
7. Lanier, L. L., Corliss, B., and Phillips, J. H. Arousal and inhibition of human NK cells. Immunol. Rev., 155: 145-154, 1997.
8. Long, E. O., Burshtyn, D. N., Clark, W. P., Peruzzi, M., Rajagopalan, S., Rojo, S., Wagtmann, N., and Winter, C. C. Killer cell inhibitory receptors: diversity, specificity, and function. Immunol Rev., 155: 135-144, 1997.
9. Colonna, M., Spies, T., Strominger, J. L., Ciccone, E., Moretta, A., Moretta, L., Pende, D., and Viale, O. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc. Natl. Acad. Sci. USA, 89: 7983-7985, 1992.
10. Borges, L., Hsu, M-L., Fanger, N., Kubin, M., and Cosman, D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol., 159: 5192-5196, 1997.
11. Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., and López-Botet, M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med., 186: 1809-1818, 1997.
12. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R., and Borges, L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol., 28: 3423-3434, 1998.
13. Braud, V. M., Allan, D. S. J., Ocallaghan, C. A., Soderstrom, K., Dandrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., and McMichael, A. J. HLA-E binds to natural killer cell receptors CD94/NKG2A. B and C. Nature (Lond.), 391: 795-799, 1998.
14. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Löpez-Botet, M., and Geraghty, D. E. HLA-E is a major ligand for the NK inhibitory receptor CD94/ NKG2A. Proc. Natl. Acad. Sci. USA, 95: 5199-5204, 1998.
15. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., and Brooks, A. G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med., 187: 813-818, 1998.
16. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., and Phillips, J. H. Immunoreceptor DAP-12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature (Lond.), 391: 703-707, 1998.
17. Lanier, L. L., Corliss, B., Wu, J., and Phillips, J. H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity, 8: 693-701, 1998.
18. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., and Parham, P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7: 739-751, 1997.
19. Bernards, R., Dessain, S. K., and Weinberg, R. A. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell, 47: 667-674, 1986.
20. Smith, M. E. F., Marsh, S. G. E., Bodmer, J. G., Gelsthorpe, K., and Bodmer, W. F. Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA, 86: 5557-5561, 1989.
21. Schrier, P. I., and Peltenburg, L. T. Relationship between myc oncogene activation and MHC class I expression. Adv. Cancer Res., 60: 181-246, 1993.
22. Singal, D. P., Ye, M., Ni, J., and Snider, D. P. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines. Immunol. Lett., 50: 149-154, 1996.
23. Cabrera, T., Fernandez, M. A., Sierra, A., Garrido, A., Herruzo, A., Escobedo, A., Fabra, A., and Garrido, F. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum. Immunol., 50: 127-134, 1996.
24. Moretta, L., Ciccone, E., Moretta, A., Höglund, P., Öhlén, C., and Kärre, K. Allorecognition by NK cells: nonself or no self? Immunol. Today, 13: 300-306, 1992.
25. 2-microglobulin-transfected Daudi cells. J. Immunol., 141: 17-20, 1988.
26. Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R., and Cresswell, P. Reversal of natural killing susceptibility in target cells expressing transfected class 1 HLA genes. Proc. Natl. Acad. Sci. USA, 86: 2361-2364, 1989.
27. Shimizu, Y., and DeMars, R. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur. J. Immunol., 19: 447-451, 1989.
28. Pérez-Villar, J. J., Melero, I., Navarro, F., Carretero, M., Bellón, T., Llano, M., Colonna, M., Geraghty, D. E., and López-Botet, M. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J. Immunol., 158: 5736-5743, 1997.
29. Phillips, J. H., Gumperz, J. E., Parham, P., and Lanier, L. L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science (Washington DC), 268: 403-405, 1995.
30. Gorelik, E., Gunji, Y., and Herberman, R. B. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity. J. Immunol., 140: 2096-2102, 1988.
31. 2m gene. J. Clin. Investig., 88: 282-289, 1991.
32. Pende, D., Accame, L., Pareti, L., Mazzocchi, A., Moretta, A., Parmiani, G., and Moretta, L. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur. J. Immunol., 28: 2384-2394, 1998.
33. Bakker, A. B. H., Phillips, J. H., Figdor, C. G., and Lanier, L. L. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells. γδ T cells, and antigen-specific CTL. J. Immunol., 160: 5239-5245, 1998.
34. Kundu, N., and Fulton, A. M. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I. and enhances NK lysis. Cell Immunol., 180: 55-61, 1997.
35. Ferlazzo, G., Semino, C., Quartarone, G., Pietra, G., and Melioli, G. Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. Tissue Antigens, 50: 459-465, 1997.
36. Blottière, H. M., Zennadi, R., Burg, C., Douillard, J. Y., Meflah, K., and Le Pendu, J. Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines. Int. J. Cancer, 50: 659-664, 1992.
37. b antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma. J. Immunol., 141: 4403-4409, 1988.
38. Dennert, G., Landon, C., Lord, E. M., Bahler, D. W., and Frelinger, J. G. Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens. J. Immunol., 140: 2472-2475, 1988.
39. Fady, C., Gardner, A. M., Gera, J. F., and Lichtenstein, A. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells. Cancer Res., 52: 764-769, 1992.
40. Stam, N. J., Kast, W. M., Voordouw, A. C., Pastoors, L. B., van der Hoeven, F. A., Melief, C. J. M., and Ploegh, H. L. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells. J. Immunol., 142: 4113-4117, 1989.
41. Pen̄a, J., Alonso, C., Solana, R., Serrano, R., Carracedo, J., and Ramirez, R. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Eur. J. Immunol., 20: 2445-2449, 1990.
42. Lichtenstein, A., Fady, C., Gera, J. F., Gardner, A., Chazin, V. R., Kelley, D., and Berenson, J. Effects of β-2 microglobulin anti-sense oligonucleotides on sensitivity of HER2/neu oncogene-expressing and nonexpressing target cells to lymphocyte-mediated lysis. Cell Immunol., 141: 219-232, 1992.
43. McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T., and Parham, P. Low HLA-C expression at cell surfaces correlates with increased turnover of mRNA. J. Exp. Med., 181: 2085-2095, 1995.
44. Kurago, Z. B., Smith, K. D., and Lutz, C. T. NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-helical mutations that affect T cells. J. Immunol., 154: 2631-2641, 1995.
45. Kurago, Z. B., Lutz, C. T., Smith, K. D., and Colonna, M. NK cell natural cytotoxicity and IFN-γ production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. J. Immunol., 160: 1573-1580, 1998.
46. Gong, J-H., Maki, G., and Klingemann, H-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia (Baltimore), 8: 652-658, 1994.
47. Campbell, K. S., and Colonna, M. Appendix I: Antibodies to human natural killer cells. In: K. S. Campbell and M. Colonna (eds.), Natural Killer Cell Protocols: Cellular and Molecular Methods, Vol. 121. Totowa, NJ: Humana Press, 2000.
48. Lutz, C. T., Smith, K. D., Greazel, N. S., Mace, B. E., Jensen, D. A., McCutcheon, J. A., and Goeken, N. E. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the α-1 helix. J. Immunol., 153: 4099-4110, 1994.
49. Smith, K. D., Mace, B. E., Valenzuela, A., Vigna, J. L., McCutcheon, J. A., Barbosa, J. A., Huczko, E., Engelhard, V. H., and Lutz, C. T. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J. Immunol., 157: 2470-2478, 1996.
50. Pross, H. F., Baines, M. G., Rubin, P., Shragge, P., and Patterson, M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J. Clin. Immunol., 1: 51-63, 1981.
51. Trinchieri, G. Biology of natural killer cells. Adv. Immunol., 47: 187-376, 1989.
52. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
53. Heo, D. S., Park, J-G., Hata, K., Day, R., Herberman, R. B., and Whiteside, T. L. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res., 50: 3681-3690, 1990,
54. Metes, D., Ernst, L. K., Chambers, W. H., Sulica, A., Herberman, R. B., and Morel, P. A. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγRIIC gene. Blood, 91: 2369-2380, 1998.
55. Maghazachi, A. A., and Al-Aoukaty, A. Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J., 12: 913-924, 1998.
56. Leibson, P. J. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity, 6: 655-661, 1997.
57. Caplan, M. J. Membrane polarity in epithelial cells: protein sorting and establishment of polarized domains. Am. J. Physiol., 272: F425-F429, 1997.
58. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., and Moretta, A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med., 187: 2065-2072, 1998.
59. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., and Moretta, A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cyloloxicity. J. Exp. Med., 188: 953-960, 1998.